EUVIMEDEUVIMED entdecken
Crossref

Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis

Zi-Wei Duan, Yong Liu, Pei-Pei Zhang, Jing-Yan Hu, Zhi-Xin Mo, Wen-Qing Liu, Xin Ma, Xiao-Hui Zhou, Xiao-Hui Wang, Xiu-Hua Hu, Sheng-Li Wei

Journal of Ethnopharmacology · 2024-09 · 331 · 118293

DOI: 10.1016/j.jep.2024.118293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2024-09. Verfasst von Zi-Wei Duan und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: 20210935115@bucm.edu.cn. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Apoptosis, Proto-Oncogene Proteins c-akt, Drugs, Chinese Herbal. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Da-Chai-Hu-Tang (DCHT), a Chinese traditional herbal compound, has been utilized for the treatment of Hepatic diseases in China for over 1800 years. The DCHT formula contains eight herbals: Bupleurum chinense DC. (chaihu), Scutellaria baicalensis Georgi (huangqin), Paeonia lactiflora Pall. (baishao), Pinellia ternata (Thunb.) Makino (banxia), Rheum officinale Baill. (dahuang), Citrus × aurantium L. (zhishi), Zingiber officinale Roscoe (shengjiang), Ziziphus jujuba Mill. (dazao). Clinical studies have demonstrated the effectiveness of DCHT in hepatocellular carcinoma (HCC) and its ability to enhance the immunity of patients with hepatocellular carcinoma. A total of 20 Chinese articles have been published on the use of DCHT in treating HCC. AIM OF THE STUDY: The study aimed to validate the effect of DCHT in HCC cells and to identify related targets (TP53, AKT1, BCL2, STAT3) in treating HCC by DCHT in vitro experiments. MATERIALS AND METHODS: Cell proliferation and migration were investigated in vitro. Flow cytometry analysis was used to evaluate the cell cycle and apoptosis. Apoptotic bodies in HepG2 cells were observed using a confocal microscope. Biochemical detection was employed to analyze LDH release, MDA levels, and SOD levels. Bioinformatics analysis was used to predict core targets between DCHT and HCC, as well as potential signaling pathways. The protein levels of metastasis-associated, apoptosis, and PI3K, AKT, p-AKT, and STAT3 were further determined through Western blotting. RESULTS: Following treatment with DCHT, the inhibition of viability, migration, and G2/M arrest was observed in HepG2 cells. Flow cytometry analysis and Morphological apoptosis studies provided evidence that DCHT could induce apoptosis in HepG2 cells. Biochemical detection revealed that DCHT could increase LDH release and the level of MDA, and inhibit the viability of the SOD. Bioinformatics analysis identified key targets such as TP53, AKT1, BCL2, STAT3. The PI3K/AKT/STAT3 signaling pathway emerged as a critical pathway in the KEGG enrichment analysis. Western blotting results indicated that DCHT could enhance the expression of E-cadherin, p53, and Bax, while reducing the content of N-cadherin, Bcl-2, PI3K, p-AKT, AKT1, and STAT3. CONCLUSIONS: The results proved that DCHT could inhibit the progression and metastasis of HCC by regulating the expression of E-cadherin, N-cadherin, p53, Bax, Bcl-2, PI3K, p-AKT, AKT, and STAT3 through the PI3K/AKT/STAT3 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorApoptosisProto-Oncogene Proteins c-aktDrugs, Chinese HerbalCell Cycle CheckpointsLiver NeoplasmsHumansHep G2 CellsCarcinoma, HepatocellularSignal TransductionPhosphatidylinositol 3-KinasesAntineoplastic Agents, PhytogenicCell MovementCell Proliferation

Stichwörter der Autor:innen

ApoptosisCell proliferationDa-Chai-Hu-TangHepatocellular carcinomaMetastasis

Substanzen

STAT3 Transcription FactorProto-Oncogene Proteins c-aktSTAT3 protein, humanDrugs, Chinese HerbalPhosphatidylinositol 3-KinasesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: 20210935115@bucm.edu.cn.
  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: yliu0126@aliyun.com.
  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: 1223671152@qq.com.
  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: hujingyan.best@163.com.
  • School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: zhsinmo@126.com.
  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: lwqing1997@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Duan, Z. W., Liu, Y., Zhang, P. P., Hu, J. Y., Mo, Z. X., Liu, W. Q., Ma, X., Zhou, X. H., Wang, X. H., Hu, X. H., & Wei, S. L. (2024). Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis. Journal of Ethnopharmacology, 331, 118293. https://doi.org/10.1016/j.jep.2024.118293

Vancouver

Duan ZW, Liu Y, Zhang PP, Hu JY, Mo ZX, Liu WQ, et al. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis. Journal of Ethnopharmacology. 2024;331:118293. doi:10.1016/j.jep.2024.118293

BibTeX
@article{Duan2024,
  author = {Duan, Zi-Wei and Liu, Yong and Zhang, Pei-Pei and Hu, Jing-Yan and Mo, Zhi-Xin and Liu, Wen-Qing and Ma, Xin and Zhou, Xiao-Hui and Wang, Xiao-Hui and Hu, Xiu-Hua and Wei, Sheng-Li},
  title = {Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis},
  journal = {Journal of Ethnopharmacology},
  year = {2024},
  volume = {331},
  pages = {118293},
  doi = {10.1016/j.jep.2024.118293}
}
Kostenlos starten →